Genolution

Genolution Interest Expense

The Interest Expense of Genolution (225220.KQ) as of Nov 19, 2026 is 2.59 B KRW. In the previous year, Interest Expense was 3.95 B KRW — a change of -34.42% (lower).

Interest Expense

2.59 BKRW

YoY

-34.42%

Last updated:

Interest Expense of Genolution is 2024 2.59 B KRW. Interest Expense of Genolution was 2023 3.95 B KRW. It decreases by -34.42% lower compared to the previous year.

The Genolution Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
-50.00 M KRW
Jan 1, 2018
1.11 B KRW
Jan 1, 2019
-437.00 M KRW
Jan 1, 2020
-10.75 B KRW
Jan 1, 2021
2.73 B KRW
Jan 1, 2022
1.87 B KRW
Jan 1, 2023
3.95 B KRW
Jan 1, 2024
2.59 B KRW
The Genolution Interest Expense history
YEARInterest ExpenseYoY
2.59 BKRW-34.42%
3.95 BKRW+111.16%
1.87 BKRW-31.48%
2.73 BKRW-125.40%
-10.75 BKRW+2,358.81%
-437.00 MKRW-139.37%
1.11 BKRW-2,320.00%
-50.00 MKRW-394.12%
17.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genolution Stock analysis

What does Genolution do? Genolution Inc develops automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also offers ribonucleic acid interference services. Its products are distributed domestically and internationally, serving customers in the biotechnology and healthcare sectors. The firm generates revenue through the sale of these products and services to research institutions, laboratories, and healthcare providers. The company's core offerings include nucleic acid extractors, reagents, and diagnostic products, which are used in molecular biology and medical diagnostics. Genolution Inc targets biotech firms, hospitals, and research facilities as key buyers of its technology. Its domestic market presence complements its international distribution channels. Genolution Inc's business model relies on selling its automated extraction devices and reagents to customers requiring efficient nucleic acid processing solutions. The company's molecular diagnostic products cater to healthcare applications, while its ribonucleic acid interference services support advanced research needs. Revenue streams are derived from both product sales and service contracts within the biotechnology industry. Genolution is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genolution stock

Interest Expense of Genolution is 2.59 B KRW in 2024.

Interest Expense of Genolution changed from 3.95 B KRW to 2.59 B KRW, representing a -34.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Genolution since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Genolution historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Genolution

All Key Metrics — Genolution